Skip to main content
. 2017 Aug 8;12(8):e0182904. doi: 10.1371/journal.pone.0182904

Table 1. Patient data.

Gender Average age (years) Time since diagnosis (years) Disease-modifying antirheumatic drugs Biological drugs
RF+ 12 female
2 male		 69.21 ± 7.93 25.00 ± 10.88 13 2
RF- 8 female
2 male		 70.90 ± 6.33 27.11 ± 12.75 6
OA 18 female
6 male		 70.31 ± 8.30